China Pharma Holdings, Inc. (CPHI) financial statements (2021 and earlier)

Company profile

Business Address 2ND FLOOR, NO. 17, JINPAN ROAD
HAINAN PROVINCE, 570216
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1112366
Cash and cash equivalents1112366
Receivables1112(16)625
Inventory, net of allowances, customer advances and progress billings445671015
Inventory445671015
Prepaid expense000000 
Other undisclosed current assets00112338
Total current assets:56912182554
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment16161924252934
Intangible assets, net (including goodwill)0000111
Intangible assets, net (excluding goodwill)0000111
Other undisclosed noncurrent assets  1724354242
Total noncurrent assets:16173748617278
TOTAL ASSETS:212245607997132
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4544654
Accounts payable4544654
Accrued liabilities0000000
Deferred revenue1 
Debt42221616
Due to related parties 221111
Customer advances and deposits1112
Other liabilities2      
Other undisclosed current liabilities01211 (10)
Total current liabilities:1110109101314
Noncurrent Liabilities
Long-term debt and lease obligation1247   
Long-term debt, excluding current maturities1247   
Operating lease, liability 0
Liabilities, other than long-term debt1 11 00
Deferred tax liabilities, net11 00
Deferred income tax liabilities1 
Other undisclosed noncurrent liabilities 1  91111
Total noncurrent liabilities:235891212
Total liabilities:13131517202526
Stockholders' equity
Stockholders' equity attributable to parent, including:8930435973106
Common stock0000000
Additional paid in capital24242424242424
Accumulated other comprehensive income12121214   
Retained earnings (accumulated deficit)(29)(26)(5)5253463
Other undisclosed stockholders' equity attributable to parent    111520
Total stockholders' equity:8930435973106
TOTAL LIABILITIES AND EQUITY:212245607997132

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues11111213162025
Cost of revenue(9)(9)(10)(11)(12)(16)(17)
Cost of goods and services sold (0)(1)(0) (3)(2)
Other undisclosed gross profit      (2)
Gross profit:2122355
Operating expenses(5)(22)(12)(21)(12)(17)(31)
Other operating income (expense), net
(Other Expenses)
    1(1)1
Other undisclosed operating loss    (0)(0)(1)
Operating loss:(3)(20)(10)(19)(8)(14)(25)
Nonoperating income (expense)(0)(0)(0)(0)000
Investment income, nonoperating0000000
Interest and debt expense(0)(0)(0)(1)1(1)1
Loss from continuing operations before equity method investments, income taxes:(3)(21)(11)(20)(7)(15)(24)
Other undisclosed income (loss) from continuing operations before income taxes0001(2) (2)
Loss from continuing operations before income taxes:(3)(21)(11)(19)(9)(15)(26)
Income tax expense (benefit)  0(0)(0)00
Loss before gain (loss) on sale of properties:(3)(21)(11)(19)(9)(15)(26)
Other undisclosed net loss      (0)
Net loss:(3)(21)(11)(19)(9)(15)(26)
Other undisclosed net loss attributable to parent     (0) 
Net loss available to common stockholders, diluted:(3)(21)(11)(19)(9)(15)(26)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(3)(21)(11)(19)(9)(15)(26)
Other comprehensive loss   (16)(14)(20)(27)
Comprehensive loss:(3)(21)(11)(35)(23)(35)(53)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1(0)(2)    
Comprehensive loss, net of tax, attributable to parent:(2)(21)(13)(35)(23)(35)(53)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: